VectorY Therapeutics, a biotechnology company advancing vectorized antibody therapies for neurodegenerative diseases, today announced the appointment of Olga Uspenskaya-Cadoz, M.D., Ph.D., as Chief ...

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

Copyright 2025 The Associated Press. All Rights Reserved. A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md ...

WASHINGTON (AP) — Sarepta Therapeutics said Tuesday that a patient died while taking its closely watched gene therapy for muscular dystrophy , sending company shares plummeting in morning trading.

Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene therapy and broader pipeline. Safety hadn’t been a major worry for ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval. Each year ...

Gene Hackman and Betsy Arakawa’s longtime contractor describes horror of finding couple’s dead bodies: ‘One of the worst days of my life’ ...

The U.S. Supreme Court this week decided to take up a case challenging a Colorado law banning so-called "conversion therapy" after a licensed Christian therapist, Kaley Chiles, claimed the law ...

The world's biggest online bookseller has quietly culled a collection of gay conversion therapy books from its catalogue. Amazon in the US bowed to pressure from LGBTQ communities earlier this month ...

It was revealed Monday that Pharma giant Bristol-Myers Squibb will acquire all outstanding shares of 2seventy bio for $5, valuing the deal at ~$286m. 2seventy bio, a Cambridge-based biotech ...